Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq Capital Market on Tuesday. The initial public offering is estimated to gross US$6 million.

The offering consists of 1.0 million common shares, initially set at 3.0 million, selling at US$6.00 per share. The company is set to trade on the Nasdaq market under the symbol “HPCO”.

Boustead Securities acts as the sole bookrunner for the said offering, which is slated to close on September 1, 2022, subject to customary closing conditions.

The California-based firm makes CBD and hemp-based cigarettes, offering smokers a non-nicotine and tobacco alternative. The company aims to take on the US$1 trillion tobacco industry with its portfolio, including its own The Real Stuff functional hemp cigarette and rolling paper brand.


Information for this briefing was found via Edgar, Investment U, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Hidden Environmental Cost of Fertilizer | Robin Dow

Could Silver Stay This High? | Joaquín Marias – Argenta Silver

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Recommended

First Majestic Drills 3.43 g/t Gold Over 24.4 Metres At Jerritt Canyon

Goliath Resources Secures 100% Ownership of Golddigger Property in BC’s Golden Triangle

Related News

Robinhood Covertly Files for US IPO

Fresh from its discomfiting Congressional hearing and onslaught of scrutiny from retail trading fanatics over...

Wednesday, March 24, 2021, 09:42:00 AM

Fitness Operator F45 Training Closes US$279 Million IPO

Fitness center franchisor F45 Training Holdings Inc. (NYSE: FXLV) closed its initial public offering Monday,...

Tuesday, July 20, 2021, 10:25:00 AM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

India-Focused Tech SPAC Cartica Acquisition Prices US$200 Million IPO

Special purpose acquisition company Cartica Acquisition Corp. (Nasdaq: CITEU) started trading on the Nasdaq Global...

Wednesday, January 5, 2022, 02:17:00 PM

Venture Capital-Backed SPAC Banner Acquisition Eyes US$150 Million IPO

Special purpose acquisition company Banner Acquisition Corp. (Nasdaq: BNNRU) started trading publicly yesterday on the...

Thursday, September 9, 2021, 12:44:00 PM